Greetings from the EM family here at USF/TGH. We have some exciting updates to share.

We are very proud of our residents and faculty who have been working hard facing the most recent Covid surge. TGH has been on the forefront of treating patients with monoclonal antibody therapy and has several active Covid-19 research trials including being selected as a site for ACTIV-6, a large clinical trial that will investigate repurposed medications. We are currently looking at ways to better reach our underserved population through mobile vaccination opportunities.

Additionally we’re very proud of two of our very own residents, Dr. Buchko and Dr. Costers, who participated in FCEP’s Case Presentation Competition, with Dr. Buchko tying for 1st place as Best Resident Discussant.

As always follow along with us at our blog for the most up-to-date news. ■